Legalising lower dosage cannabis products could 'ignite industry'

Legalising lower dosage cannabis products could 'ignite industry'
Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)
Brent Melville
Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

More Health

$920,000, predictable hours: dermatology medicine's ‘It’ job
Health

$920,000, predictable hours: dermatology medicine's ‘It’ job

Americans’ obsession with skin care has medical students flocking to the specialty.

A surprising source of dementia relief: cannabis
Health

A surprising source of dementia relief: cannabis

While marijuana can help calm agitation, there are risks.

Australian lessons for NZ’s aged care crisis
Policy

Australian lessons for NZ’s aged care crisis

“You're not providing enough home care,” a sector leader in Australia warned.

Gregor Thompson 15 Nov 2024
J&J sues US over hospital drug-discounting programme
Health

J&J sues US over hospital drug-discounting programme

It wants to change when it gives lucrative discounts to hospitals.